{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:12:22Z","timestamp":1791943942048,"version":"4.3.4"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008453","name":"American Society for Parenteral and Enteral Nutrition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Calcium oxalate nephrolithiasis is more common in persons living with cystic fibrosis (PwCF) than in the general population. A primary risk factor is exocrine pancreatic insufficiency (EPI) causing enteral hyperoxaluria. However, the relationship between nephrolithiasis and degree of EPI control has not been assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted including all PwCF seen at our institution from 2018 to 2023 (n\u2009=\u2009332). Collected data included socio-demographics, Charlson comorbidity index, EPI control status adjudicated by treating clinicians (classified as controlled, uncontrolled, or unknown), and nephrolithiasis events, which were classified as symptomatic or asymptomatic when nephrolithiasis were discovered incidentally on imaging. Incidence and lifetime prevalence rates were calculated for the entire sample and according to EPI control. A multivariable logistic regression model for the outcome of nephrolithiasis was performed using likelihood-ratio-based backwards stepwise selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cumulative lifetime prevalence of any nephrolithiasis event in our study population was 32%. The lifetime prevalence was higher in EPI (32%) than no EPI (24%), but there was no significant difference in prevalence according to EPI control status. The multivariable model identified that small bowel resection (odds ratio [OR] 3.0, 95% confidence interval (CI) 1.0\u20139.0)), alcohol use (OR 1.7, 95% CI 1.0\u20132.9), and decreased BMI (OR 0.9, 95% CI 0.9\u20131.0) were independently associated with nephrolithiasis. Among 105 individuals with nephrolithiasis, 51% (n\u2009=\u200954) had recurrent events. An invasive procedure was required by 10% (n\u2009=\u20093) with a single nephrolithiasis event and was required by 61% (n\u2009=\u200933) with recurrent nephrolithiasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nephrolithiasis events are common in PwCF. We observed an increased prevalence among PwCF with EPI, but did not observe a difference based on the degree of EPI control although this may be limited by reliance on clinician assessment of EPI control rather than a more objective measure. Prospective investigation with detailed assessment of risk factors including dietary habits and EPI control is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0340293","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:51:01Z","timestamp":1767725461000},"page":"e0340293","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and risk factors for nephrolithiasis in adults with cystic fibrosis: A retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"given":"Da Yeon","family":"Ryoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolan","family":"Ladd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Culp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3967-0581","authenticated-orcid":true,"given":"Gretchen","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Kirkby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Shidham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios I.","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-1924","authenticated-orcid":true,"given":"Mitchell L.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"11","key":"pone.0340293.ref001","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/end.2021.0151","article-title":"Systematic review of the prevalence of kidney stones in cystic fibrosis","volume":"35","author":"J Moryousef","year":"2021","journal-title":"J Endourol"},{"issue":"7","key":"pone.0340293.ref002","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ndt\/gfl067","article-title":"Factors increasing the risk for stone formation in adult patients with cystic fibrosis","volume":"21","author":"M Terribile","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0340293.ref003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1651-2227.1993.tb12667.x","article-title":"Nephrolithiasis in cystic fibrosis","volume":"82","author":"B Strandvik","year":"1993","journal-title":"Acta Paediatr"},{"issue":"3","key":"pone.0340293.ref004","first-page":"267","article-title":"Is there a risk for kidney stone formation in cystic fibrosis?","volume":"37","author":"H B\u00f6hles","year":"1982","journal-title":"Helv Paediatr Acta"},{"issue":"1","key":"pone.0340293.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00403-7","article-title":"The association of nephrolithiasis with cystic fibrosis","volume":"42","author":"EM Gibney","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"pone.0340293.ref006","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"C Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"pone.0340293.ref007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00240-015-0846-5","article-title":"The management of patients with enteric hyperoxaluria","volume":"44","author":"JR Asplin","year":"2016","journal-title":"Urolithiasis"},{"issue":"6","key":"pone.0340293.ref008","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-019-04893-z","article-title":"Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure","volume":"30","author":"E Cairoli","year":"2019","journal-title":"Osteoporosis International: A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"3","key":"pone.0340293.ref009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pan.2023.03.006","article-title":"Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis","volume":"23","author":"M Vujasinovic","year":"2023","journal-title":"Pancreatology"},{"issue":"2","key":"pone.0340293.ref010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"MS Pearle","year":"2014","journal-title":"J Urol"},{"issue":"1","key":"pone.0340293.ref011","first-page":"61","article-title":"Risk of urolithiasis in patients with cystic fibrosis","volume":"29","author":"S Campuzano","year":"2009","journal-title":"Nefrologia"},{"issue":"3","key":"pone.0340293.ref012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5414\/CNP59160","article-title":"Which factors account for renal stone formation in cystic fibrosis?","volume":"59","author":"R von der Heiden","year":"2003","journal-title":"Clin Nephrol"},{"issue":"4","key":"pone.0340293.ref013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s004670050452","article-title":"Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?","volume":"12","author":"B Hoppe","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"pone.0340293.ref014","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-5347(01)69068-2","article-title":"Metabolic risk factors for stone formation in patients with cystic fibrosis","volume":"167","author":"MR Perez-Brayfield","year":"2002","journal-title":"J Urol"},{"issue":"1","key":"pone.0340293.ref015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/03007995.2017.1389704","article-title":"Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel","volume":"34","author":"P Durie","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"9133","key":"pone.0340293.ref016","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(98)03038-4","article-title":"Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria","volume":"352","author":"H Sidhu","year":"1998","journal-title":"Lancet"},{"key":"pone.0340293.ref017","article-title":"Direct correlation between hyperoxaluria\/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy","author":"H Sidhu","year":"1999","journal-title":"J Am Soc Nephrol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:51:05Z","timestamp":1767725465000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340293"}},"subtitle":[],"editor":[{"given":"Ahmet","family":"\u00c7a\u011flar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340293","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}